STOCK TITAN

Nuwellis Inc Financials

NUWE
FY2025 annual
Revenue $8.3M -5.4% YoY
Net Income -$17.5M -56.9% YoY
EPS (Diluted) -$25.39 YoY not available
Free Cash Flow -$10.9M -12.9% YoY
Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

Nuwellis Inc (NUWE) reported $8.3M in revenue for fiscal year 2025, down 5.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI NUWE FY2025

Recurring cash consumption, not gross margin, remains the dominant mechanic as financing inflows bridge an asset-light operating model.

From FY2024 to FY2025, revenue fell to $8.3M while gross margin eased to 62.0%, indicating weaker volume and mix did not improve the economics. Operating loss remained roughly -$11.1M despite SG&A holding near $13.5M; lower overhead helped, but gross profit still could not support the operating structure.

FY2025 operating cash flow of -$10.8M nearly matched free cash flow of -$10.9M, so the deficit is primarily operating rather than capital-spending driven. Earnings quality is therefore defined by persistent cash outflow, not by a large gap between accounting loss and cash generation.

Financing inflows did not fully offset the outflow: cash fell from $5.1M in FY2024 to $1.1M in FY2025, making liquidity increasingly dependent on external funding. The current ratio narrowed to 1.7x while debt-to-equity reached 1.3x, pairing thinner short-term coverage with a more leveraged capital structure.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Cash Runway Dilution R&DIntensity Revenue Progress BurnTrend BalanceSheet 48 / 100
Financial Health Score 48/100
Scored as: Emerging companies peer group

Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Nuwellis Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Cash Runway
7
Dilution
84
R&D Intensity
45
Revenue Progress
43
Burn Trend
64
Balance Sheet
47
Altman Z-Score Distress
-76.03

Nuwellis Inc scores -76.03, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($3.3M) relative to total liabilities ($3.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/8

Nuwellis Inc passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing
N/A

Nuwellis Inc reported a net loss of $17.5M while operations used $10.8M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$8.3M
YoY-5.4%
5Y CAGR+2.1%
10Y CAGR+63.9%

Nuwellis Inc generated $8.3M in revenue in fiscal year 2025. This represents a decrease of 5.4% from the prior year.

EBITDA
-$10.9M
YoY-2.1%

Nuwellis Inc's EBITDA was -$10.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 2.1% from the prior year.

Net Income
-$17.5M
YoY-56.9%

Nuwellis Inc reported -$17.5M in net income in fiscal year 2025. This represents a decrease of 56.9% from the prior year.

EPS (Diluted)
-$25.39

Nuwellis Inc earned -$25.39 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow
-$10.9M
YoY-12.9%

Nuwellis Inc recorded an outflow of $10.9M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 12.9% from the prior year.

Cash & Debt
$1.1M
YoY-78.7%
5Y CAGR-40.4%
10Y CAGR-26.4%

Nuwellis Inc held $1.1M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding
48,112

Nuwellis Inc had 48,112 shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
62.0%
YoY-3.0pp
5Y CAGR+7.4pp

Nuwellis Inc's gross margin was 62.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 3.0 percentage points from the prior year.

Return on Equity
-667.7%
YoY-496.7pp
5Y CAGR-570.7pp
10Y CAGR-449.3pp

Nuwellis Inc's ROE was -667.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 496.7 percentage points from the prior year.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$2.7M
YoY-15.5%
5Y CAGR-5.9%
10Y CAGR-17.1%

Nuwellis Inc invested $2.7M in research and development in fiscal year 2025. This represents a decrease of 15.5% from the prior year.

Capital Expenditures
$90K
YoY+50.0%
5Y CAGR-21.3%
10Y CAGR-7.6%

Nuwellis Inc invested $90K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 50.0% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

NUWE Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

NUWE annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$9.0M$8.3M-5.4%$8.7M-1.4%$8.9M+3.8%$8.5M+7.9%$7.9M+6.5%$7.4M+35.0%$5.5M+10.3%$5.0M+40.7%$3.6M+175.6%$1.3M+2084.7%$59K-80.0%$295K+400.0%$59K$0N/A
Cost of Revenue$2.7M$3.1M+2.7%$3.1M-21.1%$3.9M+2.5%$3.8M+10.4%$3.4M+1.4%$3.4M+27.2%$2.7M-27.5%$3.7M+32.8%$2.8M+287.5%$713KN/AN/AN/AN/AN/A
Gross Profit$6.3M$5.1M-9.7%$5.7M+13.9%$5.0M+4.8%$4.8M+5.9%$4.5M+10.7%$4.1M+42.3%$2.9M+114.7%$1.3M+68.1%$790K+37.2%$576KN/AN/AN/AN/AN/A
R&D Expenses$4.2M$2.7M-15.5%$3.2M-40.8%$5.4M+24.9%$4.3M-12.8%$5.0M+35.7%$3.7M-21.5%$4.7M+53.0%$3.1M+106.1%$1.5M-81.7%$8.1M-54.1%$17.7M+4.7%$16.9M+25.0%$13.5M+68.7%$8.0M-28.5%$11.2M
SG&A Expenses$15.0M$13.5M+0.5%$13.5M-21.7%$17.2M-2.2%$17.6M-7.6%$19.0M+9.3%$17.4M+7.0%$16.3M+6.4%$15.3M+50.6%$10.2M+25.1%$8.1M-2.6%$8.3M-9.4%$9.2M-2.3%$9.4M+37.3%$6.9M+28.0%$5.4M
Operating Income-$12.9M-$11.1M-1.1%-$11.0M+37.7%-$17.6M-2.7%-$17.2M+12.1%-$19.5M-14.7%-$17.0M+6.0%-$18.1M-6.3%-$17.0M-15.0%-$14.8M+5.4%-$15.7M+39.7%-$26.0M-0.7%-$25.8M-12.7%-$22.9M-53.8%-$14.9M+10.2%-$16.6M
Interest ExpenseN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$504K-32.2%$743KN/AN/AN/AN/A
Income Tax$0$5K0.0%$5K-37.5%$8K-11.1%$9K0.0%$9K0.0%$9K+12.5%$8K+33.3%$6K0.0%$6K+111.1%-$54K+56.5%-$124K+50.2%-$249K+79.5%-$1.2M-57.3%-$771K-570.4%-$115K
Net Income-$11.3M-$17.5M-56.9%-$11.2M+44.8%-$20.2M-39.1%-$14.5M+25.7%-$19.6M-23.5%-$15.8M+12.6%-$18.1M-6.4%-$17.0M-27.3%-$13.4M+15.3%-$15.8M+40.6%-$26.6M-3.9%-$25.6M-17.6%-$21.8M-54.7%-$14.1M+13.2%-$16.2M
EPS (Diluted)-$25.39-$353.30-$360.06-$83.55-$285.36-$10.67N/AN/AN/AN/AN/AN/AN/AN/AN/A

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

NUWE Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

NUWE annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$6.1M-38.0%$9.9M+1.0%$9.8M-60.4%$24.7M-18.9%$30.4M+52.0%$20.0M+257.2%$5.6M-36.2%$8.8M-52.4%$18.5M+147.0%$7.5M-69.4%$24.4M-24.5%$32.4M-41.4%$55.2M+267.3%$15.0M+102.3%$7.4M
Current Assets$5.2M-41.4%$8.9M+7.9%$8.2M-63.9%$22.8M-19.0%$28.1M+51.7%$18.5M+359.3%$4.0M-50.3%$8.1M-54.5%$17.9M+638.5%$2.4M-89.7%$23.6M-25.6%$31.7M-42.0%$54.6M+275.4%$14.6M+110.7%$6.9M
Cash & Equivalents$1.1M-78.7%$5.1M+34.1%$3.8M-78.6%$17.7M+102.9%$8.7M-39.4%$14.4M+1028.8%$1.3M-76.7%$5.5M-64.9%$15.6M+1078.8%$1.3M-94.3%$23.1M-26.1%$31.3M-42.2%$54.1M+280.6%$14.2M+116.7%$6.6M
Inventory$1.9M+11.2%$1.7M-14.0%$2.0M-25.0%$2.7M-6.4%$2.8M-3.9%$3.0M+64.6%$1.8M+8.4%$1.7M+4.4%$1.6M+134.6%$677KN/AN/AN/AN/AN/A
Accounts Receivable$1.5M-13.5%$1.7M-11.5%$2.0M+38.8%$1.4M+87.5%$750K-17.1%$905K+13.3%$799K+1.7%$786K+44.2%$545K+93.3%$282KN/A$59K0.0%$59KN/AN/A
GoodwillN/AN/AN/AN/AN/AN/AN/AN/A$0-100.0%$189KN/AN/AN/AN/AN/A
Total Liabilities$3.5M+4.6%$3.3M-49.2%$6.6M-46.7%$12.3M+175.5%$4.5M+21.0%$3.7M+2.3%$3.6M+27.2%$2.8M+28.1%$2.2M-57.6%$5.2M-57.4%$12.3M+288.8%$3.2M-9.8%$3.5M+67.8%$2.1M-26.4%$2.8M
Current Liabilities$3.0M+18.5%$2.6M-19.3%$3.2M-32.3%$4.7M+41.8%$3.3M-7.8%$3.6M+7.0%$3.4M+18.0%$2.8M+35.8%$2.1M-35.9%$3.3M-59.2%$8.0M+153.3%$3.2M-9.8%$3.5M+67.8%$2.1M-26.4%$2.8M
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$3.9MN/AN/AN/AN/A
Total Equity$2.6M-59.8%$6.5M+118.3%$3.0M-75.8%$12.4M-52.4%$25.9M+59.0%$16.3M+720.0%$2.0M-66.5%$5.9M-63.4%$16.2M+824.2%$1.8M-85.6%$12.2M-58.3%$29.2M-43.5%$51.7M+299.5%$12.9M+181.7%$4.6M
Retained Earnings-$316.3M-5.9%-$298.8M-3.9%-$287.6M-7.6%-$267.4M-5.7%-$252.9M-8.4%-$233.3M-7.3%-$217.5M-9.1%-$199.4M-9.3%-$182.4M-7.9%-$169.0M-10.3%-$153.2M-21.0%-$126.6M-25.3%-$101.0M-27.5%-$79.3M-21.6%-$65.2M

NUWE Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

NUWE annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow-$12.5M-$10.8M-12.7%-$9.6M+46.5%-$17.9M-18.4%-$15.1M+15.1%-$17.8M-7.7%-$16.6M-1.3%-$16.4M-12.4%-$14.6M-22.1%-$11.9M+26.8%-$16.3M+29.1%-$23.0M-1.5%-$22.6M-30.4%-$17.4M-32.7%-$13.1M0.0%-$13.1M
Capital Expenditures$125K$90K+50.0%$60K-59.7%$149K+22.1%$122K-44.3%$219K-26.5%$298K-39.2%$490K+147.5%$198K-23.6%$259K+121.4%$117K-41.2%$199K-43.3%$351K+19.8%$293K+85.4%$158K-65.0%$451K
Free Cash Flow-$12.6M-$10.9M-12.9%-$9.7M+46.6%-$18.1M-18.4%-$15.3M+15.5%-$18.1M-7.1%-$16.9M-0.1%-$16.9M-14.2%-$14.8M-21.2%-$12.2M+25.8%-$16.4M+29.2%-$23.2M-0.8%-$23.0M-30.2%-$17.7M-33.3%-$13.2M+2.2%-$13.5M
Investing Cash Flow-$379K-$90K-50.0%-$60K-118.2%$330K-97.8%$14.7M+193.7%-$15.7M-5787.3%-$267K+45.5%-$490K-147.5%-$198K+23.6%-$259K+93.7%-$4.1MN/AN/AN/AN/AN/A
Financing Cash Flow$12.4M$6.9M-36.7%$11.0M+197.6%$3.7M-60.9%$9.4M-66.2%$27.9M-7.1%$30.0M+137.0%$12.7M+172.5%$4.6M-82.4%$26.5M+2039.4%-$1.4MN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

NUWE Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

NUWE annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin62.0%-3.0pp64.9%+8.7pp56.2%+0.6pp55.7%-1.0pp56.7%+2.2pp54.5%+2.8pp51.7%+25.2pp26.6%+4.3pp22.2%-22.5pp44.7%N/AN/AN/AN/AN/A
Operating Margin-134.3%-125.7%-198.9%-201.0%-246.5%-228.8%-328.5%-340.9%-416.9%-1215.0%-43996.6%-8741.4%-38764.4%N/AN/A
Net Margin-211.9%-127.8%-228.0%-170.0%-246.9%-212.8%-328.7%-340.8%-376.6%-1225.1%-45055.9%-8673.6%-36878.0%N/AN/A
Return on Equity-667.7%-496.7pp-171.0%+504.9pp-675.9%-558.4pp-117.5%-42.2pp-75.4%+21.7pp-97.0%+813.2pp-910.2%-623.3pp-286.9%-204.5pp-82.4%+816.4pp-898.8%-680.4pp-218.4%-130.8pp-87.6%-45.5pp-42.1%+66.6pp-108.6%+243.8pp-352.4%
Return on Assets-286.4%-173.2pp-113.2%+93.7pp-206.8%-148.0pp-58.9%+5.4pp-64.3%+14.8pp-79.1%+244.2pp-323.3%-129.3pp-194.1%-121.6pp-72.5%+138.9pp-211.4%-102.7pp-108.7%-29.7pp-79.0%-39.6pp-39.4%+54.1pp-93.5%+124.4pp-217.9%
Current Ratio1.71-1.7x3.46+0.9x2.59-2.3x4.86-3.6x8.51+3.3x5.17+4.0x1.20-1.7x2.86-5.7x8.54+7.8x0.74-2.2x2.95-7.1x10.04-5.6x15.60+8.6x6.98+4.5x2.44
Debt-to-Equity1.33+0.8x0.51-1.7x2.19+1.2x1.00+0.8x0.17-0.1x0.23-1.6x1.82+1.3x0.48+0.3x0.14-2.8x2.98+2.7x0.32+0.2x0.110.0x0.07-0.1x0.16-0.5x0.62
FCF Margin-131.8%-110.4%-204.0%-178.8%-228.0%-226.7%-305.9%-295.3%-342.8%-1273.0%-39301.7%-7794.9%-29923.7%N/AN/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Frequently Asked Questions

What is Nuwellis Inc's annual revenue?

Nuwellis Inc (NUWE) reported $8.3M in total revenue for fiscal year 2025. This represents a -5.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Nuwellis Inc's revenue growing?

Nuwellis Inc (NUWE) revenue declined by 5.4% year-over-year, from $8.7M to $8.3M in fiscal year 2025.

Is Nuwellis Inc profitable?

No, Nuwellis Inc (NUWE) reported a net income of -$17.5M in fiscal year 2025.

Nuwellis Inc (NUWE) reported diluted earnings per share of -$25.39 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Nuwellis Inc (NUWE) had EBITDA of -$10.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Nuwellis Inc (NUWE) had a gross margin of 62.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Nuwellis Inc (NUWE) has a return on equity of -667.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Nuwellis Inc (NUWE) recorded an outflow of $10.9M in free cash flow during fiscal year 2025. This represents a -12.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Nuwellis Inc (NUWE) recorded an outflow of $10.8M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Nuwellis Inc (NUWE) had $6.1M in total assets as of fiscal year 2025, including both current and long-term assets.

Nuwellis Inc (NUWE) invested $90K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Nuwellis Inc (NUWE) invested $2.7M in research and development during fiscal year 2025.

Nuwellis Inc (NUWE) had 48,112 shares outstanding as of fiscal year 2025.

Nuwellis Inc (NUWE) had a current ratio of 1.71 as of fiscal year 2025, which is generally considered healthy.

Nuwellis Inc (NUWE) had a debt-to-equity ratio of 1.33 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Nuwellis Inc (NUWE) had a return on assets of -286.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Based on fiscal year 2025 data, Nuwellis Inc (NUWE) had $1.1M in cash against an annual operating cash burn of $10.8M. This gives an estimated cash runway of approximately 1 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Nuwellis Inc (NUWE) has an Altman Z-Score of -76.03, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Nuwellis Inc (NUWE) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Nuwellis Inc (NUWE) reported a net loss of $17.5M while operations used $10.8M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Nuwellis Inc (NUWE) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top